Dako, Quintiles Partner on Personalized Rx; First Project to Focus on AstraZeneca Cancer Rx

Dako and Quintiles have joined forces to develop companion diagnostics and drugs and to work with pharma to bring personalized medicine products to market.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.